Growth Metrics

Lucid Diagnostics (LUCD) FCF Margin Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -80.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 473.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 23.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -431.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1,716.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2,811.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2,833.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 192.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 261.00
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 56,928.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 56,928.00
Dec 31, 2025 559.00
Sep 30, 2025 -4,191.00
Jun 30, 2025 29,527.00
Mar 31, 2025 -25,303.00
Dec 31, 2024 13,006.00
Sep 30, 2024 25,507.00
Jun 30, 2024 319,589.00
Mar 31, 2024 33,659.00
Dec 31, 2023 300,669.00
Sep 30, 2023 525,965.00
Mar 31, 2023 153,417.00
Dec 31, 2022 -41,604.00
Sep 30, 2022 -527,789.00